Filing Flows

Filing Flows › Innovex International (INVX) › Q3 2025

Innovex International (INVX) Q3 2025 earnings results (third quarter 2025)

10-Q filed Nov 4, 2025

Innovex International (INVX) reported revenue of $240M for the third quarter 2025 (Q3 2025), +58% from a year earlier and +7% from the quarter before. Operating margin was 26.0%, net earnings $39.2M (16.3% of revenue).

Revenue$240M
Year over year+58%
Quarter over quarter+7%
Operating margin26.0%
Net earnings$39.2M

Innovex International, Q3 2025: revenue $240M (+58% year over year), operating margin 26.0%, net earnings $39.2M, operating cash flow $48.4M. The chart follows the revenue to costs, profit and cash.

Q3 2025AmountQ/QY/Y
Revenue$240M+7%+58%
Operating profit$62.3M+174%—
Net earnings$39.2M+156%-53%
Operating cash flow$48.4M-18%+123%
Free cash flow$36.5M—+82%

What changed

Revenue was $240.0M in Q3 2025, up 58% year over year and up 7% from the previous quarter. Product was the largest line at 69% of revenue. Product added $39.2M year over year (up 31%), 44% of the total change.

Operating profit was $62.3M, a 26.0% margin (up 34.7 points year over year). Total costs grew 8% against revenue growth of 58%. Net earnings were $39.2M, down 53% year over year. The effective tax rate was 32.3%.

Operating cash flow was $48.4M (up 123% year over year), 123% of net earnings. Non-cash charges added back $15.4M of depreciation and amortization and $3.2M of share-based compensation. Working capital and other items used $9.5M. After capital expenditures ($11.9M), free cash flow as the company reports it was $36.5M.

Questions

What was Innovex International's revenue in the third quarter 2025?

Innovex International (INVX) reported revenue of $240M for the third quarter 2025 (Q3 2025), +58% from a year earlier and +7% from the quarter before.

Was Innovex International profitable in the third quarter 2025?

Operating profit was $62.3M (26.0% of revenue) and net earnings $39.2M.

Open the interactive Sankey →

Source: Innovex International 10-Q on SEC EDGAR.